OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Eli Lilly & Co.
Douglas G. Muse is consultant—Compendial Affairs, Eli Lilly & Co.
February 03, 2021
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
October 01, 2019
This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.
September 01, 2018
Increasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.